Israel-based Cardiosonic announced it is currently enrolling patients in the TIVUS II clinical trial, designed to assess the safety, efficacy and performance of its TIVUS system using a next generation multidirectional catheter. TIVUS ...
Tags: Cardiosonic, Clinical Trial
Santen Pharmaceutical, a manufacturer of ophthalmic and anti-rheumatic pharmaceuticals, has introduced TAPROS MINI ophthalmic solution 0.0015%, indicated for glaucoma and ocular hypertension. TAPROS MINI ophthalmic solution contains ...
Sotera Wireless, a medical device company, has obtained an approval from the US Food and Drug Administration (FDA) for its continuous non-invasive blood pressure (cNIBP) technology, a new feature of the ViSi Mobile wireless patient ...
Tags: cNIBP Technology, Sotera Wireless
Bayer HealthCare Pharmaceuticals, a subsidiary of Bayer, has obtained the US Food and Drug Administration (FDA) approval for its Adempas (riociguat) tablets. Adempas tablets are developed for the treatment of adults with ...
Bayer HealthCare Pharmaceuticals, a subsidiary of Bayer, has obtained two separate orphan drug designations from the US Food and Drug Administration's (FDA) Office of Orphan Products Development for its investigational, oral medication ...
Tags: Drug Designations, Medicine
Medtronic has unveiled new data from the Global SYMPLICITY Registry, a multi-centre, prospective, observational registry designed to collect comprehensive data evaluating procedural and long-term safety of the Symplicity renal denervation ...
Tags: Medtronic, Symplicity Registry
The US FDA has approved Silvergate Pharmaceuticals' Epaned (enalapril maleate Powder for Oral Solution) to treat hypertension (high blood pressure) in people aged one month and more. Silvergate Pharmaceuticals president and CEO Frank ...
The US Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee has recommended approval of Bayer’s oral soluble guanylate cyclase (sGC) stimulator, riociguat, in two forms of pulmonary ...
Tags: FDA Advisory Committee
Toa Eiyo has received manufacturing and marketing authorization for Bisono Tape 4mg and 8mg medicines (Bisono Tape) in Japan from the Japanese Ministry of Health, Labour and Welfare (MHLW). Developed by Nitto Denko in partnership with Toa ...
Daiichi Sankyo Espha, Japan-based generics subsidiary of Daiichi Sankyo, has launched three new generic drugs, Pramipexole hydrochloride 0.125mg tablets DSEP, Pramipexole hydrochloride 0.5mg tablets DSEP and Amlodipine 10mg tablets DSEP, ...
Takeda Pharmaceutical Company said it will start using bio-polyethylene bottles (“Bio-PE bottles”) as the primary packaging container for the hypertension treatment product, Azilva. Made from plastic derived from ...
Tags: Takeda Pharma, Packaging, Bottles
Australia-based medical devices company Uscom has entered into an agreement to acquire New Zealand-based Pulsecor by offering five million fully paid ordinary Uscom shares. Under the terms of the agreement, Uscom will acquire all Pulsecor ...
St. Jude Medical, a medical device firm, has announced that its EnligHTN Multi-Electrode Renal Denervation System offers a safe, rapid and sustained reduction in measurements of blood pressure after a year. The company presented the new ...
Tags: EnligHTN Renal, Blood Pressure
Medtronic has completed randomizing Symplicity HTN-3, a clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. Renal denervation is a minimally invasive, catheter-based procedure that decreases the ...
Tags: Medtronic, Randomizing Symplicity
US-based medical device company St Jude Medical has commenced its EnligHTNment clinical study. The EnligHTNment study will assess whether the EnligHTN Multi-Electrode Renal Denervation System can minimize the risk of major cardiovascular ...
Tags: St Jude Medical, Clinical Study